Peripheral Nerve Stimulation for Painful Mononeuropathy Secondary to Leprosy: A 12-Month Follow-Up Study.
- Tiago da Silva Freitas,
- Erich Talamoni Fonoff,
- Oswaldo Ribeiro Marquez Neto,
- Iruena Moraes Kessler,
- Laura Mendes Barros,
- Ronan Wilk Guimaraes,
- Monalisa Ferreira Azevedo
Neuromodulation 2017 Oct 29. Epub 2017 Oct 29.
Department of Endocrinology, University Hospital of Brasília, Brasilia, Brazil.
Objective: Leprosy affects approximately 10-15 million patients worldwide and remains a relevant public health issue. Chronic pain secondary to leprosy is a primary cause of morbidity, and its treatment remains a challenge. We evaluated the feasibility and safety of peripheral nerve stimulation (PNS) for painful mononeuropathy secondary to leprosy that is refractory to pharmacological therapy and surgical intervention (decompression). Read More